NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

消費者用氧氣設備市場:2021年至2026年的預測

Consumer Oxygen Equipment Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023214
出版日期 內容資訊 英文 109 Pages
商品交期: 最快1-2個工作天內
價格
消費者用氧氣設備市場:2021年至2026年的預測 Consumer Oxygen Equipment Market - Forecasts from 2021 to 2026
出版日期: 2021年07月09日內容資訊: 英文 109 Pages
簡介

全球消費者用氧氣設備的市場規模,從2019年的68億7,300萬美元,在預測期間內預計以8.04%的年複合成長率成長,2026年達到118億1,200萬美元。

在預測期間內帶動市場成長的主要理由,是在投藥目的的氧需求增加。公害增加加上惡劣的環境,肺相關的疾病和呼吸系統的障礙發生顯著增加著。再加上技術創新,製造容易搬運的可攜帶式氧氣設備,市場規模大幅度擴大。隨著氣喘和肺癌症增加,為了更佳治療和健康,對氧設備的市場的需求也提高。

本報告提供全球消費者用氧氣設備市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各類型,各地區的市場規模的變化與預測,競爭情形,並提供主要企業簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供給企業談判力
    • 買主談判力
    • 替代品的威脅
    • 新加入業者的威脅
    • 產業的競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 各類型消費者用氧氣設備市場

  • 簡介
  • 氧氣濃縮機
  • 壓縮氣體系統
  • 液體氧系統

第6章 各終端用戶消費者用氧氣設備市場

  • 簡介
  • 醫院和診所
  • 居家護理

第7章 各地區的消費者用氧氣設備市場

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 日本
    • 其他

第8章 競爭環境與分析

  • 主要的參與者與策略分析
  • 新興參與者和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第9章 企業簡介

  • Precision Medical Inc.
  • Boost Oxygen LLC
  • Nidek Medical Products Inc.
  • Philips Healthcare
  • Drive DeVilbiss international
  • Invacare Corporation
  • Chart industries
  • Inogen Inc
  • Summit Oxygen international
  • Oxygen Plus Inc.
  • Foshan Shunde bond Electronics Co.
  • ABC Healthcare
目錄
Product Code: KSI061610680

The global consumer oxygen equipment market is projected to grow at a CAGR of 8.04% during the forecast period to reach US$11.812 billion by 2026, from US$6.873 billion in 2019. The prime reason driving the market growth during the forecasted period is the rising demand for oxygen for medication purposes. An increasing level of pollution coupled with an unfavorable environment has significantly increased instances of lung-related diseases and breathing disorders. Patients suffering from cancer, chronic obstructive pulmonary disease (COPS), or any other disorders find it difficult to breathe since their lungs are unable to extract enough oxygen from the air they breathe in. These patients then rely on oxygen equipment for aid. Further, technological innovation has resulted in the manufacturing of portable oxygen concentrators which are easier to carry, increasing the market scope significantly.

Rising cases of asthma and lung cancer have created a significant market demand for oxygen equipment for better aid and health.

Asthma and lung cancer patients are the prime users of consumer oxygen equipment. Rising instances of these chronic diseases are the prime reason driving the market demand for oxygen equipment. Research by the World Health Organization (WHO) found that 2.2 million new lung cancer cases were discovered in 2020, the second highest in the year. However, lung cancer was the leading reason for cancer-related deaths, taking 1.8 million lives. Increasing pollution coupled with rising consumption of tobacco is anticipated to increase the cases of cancer and other lung-linked chronic diseases in the coming years, requiring medical attention for prevention and treatment. Hence, the oxygen equipment market will observe significant market growth during the forecasted period.

The coronavirus is another breathe-linked disease that has severely affected the global economy. The outbreak of the virus has boosted the demand for oxygen equipment at an exponential rate. Coronavirus affects the respiratory functions of the body, making it difficult for the infected patients to breathe and hence causing death. The outbreak of the virus has accelerated the oxygen demand and linked equipment at an exponential level. Particularly during the second wave of the virus which caused more death due to higher name of per day cases and oxygen linked shortage. The limited supply of oxygen and/ or supporting equipment increased the number of preventable fatalities. Hence, to ensure sufficient oxygen and equipment supply, WHO, partnered and distributed over 30,000 concentrators and more than 40,000 oximeters and patient monitors, especially in 37 countries classified as "fragile".

Oxygen Concentrators in a homebound medication system saw a skyrocketing market size amid the pandemic which is anticipated to resume to normal rates during the forecasted period.

Oxygen concentrators are commonly used oxygen equipment by patients in a homebound medication environment. Portal oxygen concentrators are anticipated to dominate the market during the forecasted period. Owing to their portability, ease to carry, and low cost these concentrators are widely adaptable. Further, rising favourability for home medication since it cost less than in-hospital treatment, has significantly inclined the market trends towards concentrators.

During the peak of the virus, hospitals globally observed a boom in the number of patients rushing for treatment and other facilities. However, limitations of beds and other equipment constrained proper treatment. Hence, infected people with the least severity were advised to adopt homebound medication through oxygen concentrators which significantly increased the market scope. Further, skyrocketing cases and limited resources increased the demand for oxygen concentrators in the retail division. However, financial constraints and loss of income amid lockdown and increasing unemployment hindered the market. As support, several international organizations and companies tied up to provide the demand shortage. Hindustan Unilever, for instance, partnered with Portea Medical to supply 4,000 oxygen concentrators in India, to fight against the devastating second wave.

Demand for oxygen equipment boomed in the Asia Pacific region amid the outbreak of the virus. However, the North American consumer oxygen market will have a significant market share during the forecasted period.

Based on geography, the global consumer oxygen equipment market is segmented into North America, South America, Europe, Middle East, and Africa, and the Asia Pacific region. The North American region is projected to hold a significant share in the consumer oxygen equipment industry. the rising instance of lung-related chronic diseases along with better healthcare infrastructure and resources support the market growth during the forecasted period. In the US, lung cancer is the third largest disease-causing cancer-linked death. In 2020, 235,760 new cases were recorded in the country while the diseases caused 131,880 deaths. Rising cases of lung cancer along with other chronic diseases such as asthma and obesity have increased the demand for oxygen equipment in the region.

The Asia Pacific region, however, is projected to show robust demand amid pandemics. A surge in cases of patients was observed, particularly in the second wave of the virus, across the region, especially in India, Singapore, Thailand, and others. The severity of this wave caused a hike in demand for oxygen equipment in the region. The prediction of a third wave has increased the concerns of healthcare authorities and increased the demand for oxygen equipment to reduce covid linked fatalities and deaths.

Market Segmentation:

  • By Type
  • Oxygen Concentrators
  • Compressed Gas Systems
  • Liquid Oxygen Systems
  • By End-User
  • Hospitals & Clinics
  • Homecare
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Taiwan
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Powers of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. The threat of New Entrants
    • 4.3.5. Competitive Rivalry in Industry
  • 4.4. Industry Value Chain Analysis

5. Consumer Oxygen Equipment Market, by Type

  • 5.1. Introduction
  • 5.2. Oxygen Concentrators
  • 5.3. Compressed Gas Systems
  • 5.4. Liquid Oxygen Systems

6. Consumer Oxygen Equipment Market, by End Users

  • 6.1. Introduction
  • 6.2. Hospitals & Clinics
  • 6.3. Homecare

7. Consumer Oxygen Equipment Market, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Israel
    • 7.5.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. South Korea
    • 7.6.4. Taiwan
    • 7.6.5. Thailand
    • 7.6.6. Indonesia
    • 7.6.7. Japan
    • 7.6.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrative
  • 8.3. Mergers, Acquisition, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles

  • 9.1. Precision Medical Inc.
  • 9.2. Boost Oxygen LLC
  • 9.3. Nidek Medical Products Inc.
  • 9.4. Philips Healthcare
  • 9.5. Drive DeVilbiss international
  • 9.6. Invacare Corporation
  • 9.7. Chart industries
  • 9.8. Inogen Inc
  • 9.9. Summit Oxygen international
  • 9.10. Oxygen Plus Inc.
  • 9.11. Foshan Shunde bond Electronics Co.
  • 9.12. ABC Healthcare